Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
MEDP

MEDP - Medpace Holdings Inc Stock Price, Fair Value and News

421.14USD-2.82 (-0.67%)Market Closed

Market Summary

MEDP
USD421.14-2.82
Market Closed
-0.67%

MEDP Stock Price

View Fullscreen

MEDP RSI Chart

MEDP Valuation

Market Cap

13.0B

Price/Earnings (Trailing)

41.75

Price/Sales (Trailing)

6.65

EV/EBITDA

32.6

Price/Free Cashflow

27.57

MEDP Price/Sales (Trailing)

MEDP Profitability

EBT Margin

18.47%

Return on Equity

46.54%

Return on Assets

17.4%

Free Cashflow Yield

3.63%

MEDP Fundamentals

MEDP Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

17.73%

Rev. Growth (Qtr)

2.54%

MEDP Earnings

Earnings (TTM)

312.5M

Earnings Growth (Yr)

40.74%

Earnings Growth (Qtr)

31.03%

Breaking Down MEDP Revenue

Last 7 days

-4.9%

Last 30 days

4.5%

Last 90 days

13.2%

Trailing 12 Months

70.6%

How does MEDP drawdown profile look like?

MEDP Financial Health

Current Ratio

0.78

MEDP Investor Care

Shares Dilution (1Y)

1.59%

Diluted EPS (TTM)

9.81

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.0B000
20231.6B1.7B1.8B1.9B
20221.2B1.3B1.4B1.5B
2021955.0M1.0B1.1B1.1B
2020891.1M882.0M896.1M925.9M
2019742.3M786.2M823.2M861.0M
2018492.6M556.5M625.2M704.6M
2017428.6M428.9M431.7M436.2M
2016374.7M390.3M406.0M421.6M
2015000359.1M
20140000
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Medpace Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 30, 2024
mccarthy cornelius p. iii
acquired
-
-
62.00
-
Jun 30, 2024
kraft robert o.
acquired
-
-
72.00
-
Jun 30, 2024
carley brian t
acquired
-
-
78.00
-
Jun 05, 2024
burwig susan e
sold
-3,081,620
401
-7,681
exec. vp, operations
May 28, 2024
troendle august j.
sold
-2,252,320
395
-5,695
ceo
May 24, 2024
troendle august j.
sold
-1,575,740
395
-3,987
ceo
May 22, 2024
troendle august j.
sold
-22,000
400
-55.00
ceo
May 20, 2024
troendle august j.
sold
-1,608,760
400
-4,020
ceo
May 16, 2024
troendle august j.
sold
-2,845,820
403
-7,060
ceo

1–10 of 50

Which funds bought or sold MEDP recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 19, 2024
First Pacific Financial
new
-
2,472
2,472
-%
Jul 19, 2024
Integrated Investment Consultants, LLC
unchanged
-
-
257,848
0.07%
Jul 19, 2024
Venturi Wealth Management, LLC
unchanged
-
339
18,122
-%
Jul 19, 2024
Sumitomo Mitsui Trust Holdings, Inc.
unchanged
-
13,522
723,209
-%
Jul 19, 2024
HARBOR INVESTMENT ADVISORY, LLC
reduced
-18.22
-18,109
90,607
0.01%
Jul 19, 2024
RAYMOND JAMES & ASSOCIATES
added
13.13
2,988,220
22,542,600
0.01%
Jul 19, 2024
Raymond James Financial Services Advisors, Inc.
added
29.08
294,558
1,228,550
-%
Jul 19, 2024
Apollon Wealth Management, LLC
added
13.98
33,153
238,461
0.01%
Jul 19, 2024
First Horizon Advisors, Inc.
reduced
-7.62
-7,771
124,790
-%
Jul 19, 2024
Bellecapital International Ltd.
sold off
-100
-259,464
-
-%

1–10 of 50

Are Funds Buying or Selling MEDP?

Are funds buying MEDP calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MEDP
No. of Funds

Unveiling Medpace Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Mar 08, 2024
troendle august j.
19.4%
6,071,852
SC 13D/A
Feb 28, 2024
troendle august j.
20.8%
6,496,852
SC 13D/A
Feb 13, 2024
vanguard group inc
8.33%
2,556,443
SC 13G/A
Feb 09, 2024
wasatch advisors lp
-
0
SC 13G/A
Jan 26, 2024
blackrock inc.
7.9%
2,417,994
SC 13G/A
Dec 05, 2023
troendle august j.
21.9%
6,810,606
SC 13D/A
Sep 22, 2023
troendle august j.
23.0%
7,135,606
SC 13D/A
Feb 09, 2023
vanguard group inc
8.67%
2,696,146
SC 13G/A
Feb 08, 2023
wasatch advisors inc
-
0
SC 13G/A
Jan 26, 2023
blackrock inc.
10.2%
3,163,001
SC 13G/A

Recent SEC filings of Medpace Holdings Inc

View All Filings
Date Filed Form Type Document
Jul 03, 2024
3
Insider Trading
Jul 03, 2024
4
Insider Trading
Jul 03, 2024
8-K
Current Report
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
4
Insider Trading
Jun 07, 2024
4
Insider Trading
Jun 05, 2024
144
Notice of Insider Sale Intent
May 29, 2024
4
Insider Trading
May 24, 2024
4
Insider Trading

Peers (Alternatives to Medpace Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
180.4B
23.7B
-5.41% 12.43%
40.98
7.6
-8.94% -35.91%
38.7B
3.7B
-7.03% -13.75%
44.62
10.38
8.57% 23.94%
38.5B
6.6B
-2.30% 5.82%
30.96
5.83
-6.38% -8.07%
16.2B
9.3B
6.34% 1.67%
19.17
1.75
-3.29% 6.68%
13.0B
2.0B
4.50% 70.57%
41.75
6.65
25.57% 21.62%
13.0B
1.2B
-1.84% 123.25%
-35.62
10.77
39.26% 33.08%
11.2B
4.1B
4.05% 7.02%
25.3
2.73
0.49% -10.45%
MID-CAP
8.6B
2.5B
11.64% -50.70%
-35.95
3.41
15.21% 53.51%
3.8B
603.7M
2.74% -17.56%
-8.17
6.23
25.21% 30.68%
3.5B
929.2M
-2.97% -26.96%
2.3K
3.81
28.93% 111.61%
SMALL-CAP
942.7M
275.1M
28.64% 80.46%
-5.15
3.43
-13.93% -126.97%
94.1M
31.1M
16.81% -87.36%
-1.22
3.02
0.95% 19.75%
18.8M
9.0M
-7.93% -45.09%
-1.28
2.09
4.46% 45.80%
393.9K
5.5M
-13.04% -71.63%
-0.03
0.07
-68.52% -143.74%
183.8K
-
-50.00% -94.83%
-0.01
0.01
- -

Medpace Holdings Inc News

Latest updates
MarketBeat3 hours ago
Yahoo Finance19 Jul 202403:50 pm
American Banking and Market News19 Jul 202402:46 pm

Medpace Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue2.5%511498492461434394384351331309296278260260230205231230216214201
Costs and Expenses-1.0%407411408382348318306291267254242236212205184175195194186179175
  S&GA Expenses3.7%44.0043.0041.0039.0038.0033.0035.0033.0029.0028.0028.0027.0026.0022.0023.0022.0025.0021.0029.0024.0021.00
EBITDA Margin2.7%0.20*0.19*0.19*0.20*0.21*0.21*0.21*0.20*0.19*0.19*0.20*0.20*0.20*--------
Income Taxes-17.9%10.0012.0013.0015.0013.005.0016.0013.004.006.006.003.005.004.006.006.008.006.005.007.005.00
Earnings Before Taxes24.3%11391.0083.0076.0086.0074.0082.0062.0065.0056.0055.0043.0049.0055.0047.0030.0036.0036.0029.0034.0025.00
EBT Margin3.7%0.18*0.18*0.18*0.19*0.19*0.19*0.19*0.19*0.18*0.18*0.18*0.19*0.19*--------
Net Income31.0%10378.0071.0061.0073.0069.0066.0049.0061.0050.0049.0040.0043.0051.0041.0024.0029.0030.0024.0027.0019.00
Net Income Margin6.2%0.16*0.15*0.15*0.16*0.16*0.17*0.16*0.16*0.16*0.16*0.17*0.17*0.17*--------
Free Cashflow0.5%14714610674.0071.0012710185.0037.0062.0066.0057.0051.00--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets8.4%1,7961,6571,4871,4071,3961,3521,3281,3151,3441,6601,5771,4701,4511,3911,2961,2221,1381,1431,0721,0171,007
  Current Assets25.4%745594449379368334338329356691641550533474395319303317250194182
    Cash Equivalents65.8%40724595.0039.0047.0028.0031.0043.0083.0046139833933327821916113413279.0020.0030.00
  Net PPE-1.6%11912111511511411010510499.0093.0088.0086.0085.0085.0071.0066.0050.0047.0044.0040.0038.00
  Goodwill0%662662662662662662662662662662662662662662662662662662662662662
Liabilities2.4%1,1241,0981,0161,0161,0489669791,032739707679618592585505484420417380359385
  Current Liabilities3.4%957925849852882803821879579557517473447440358338339343314296265
  Short Term Borrowings----55.0011550.00140250-------------
  Long Term Debt---------------------56.00
    LT Debt, Non Current---------------------56.00
Shareholder's Equity20.1%672559471391347386350283605953898852859806792738718726692658622
  Retained Earnings46.2%-119-221-300-371-408-359-380-446-12023518514215911511270.0054.0068.0038.0014.00-13.14
  Additional Paid-In Capital1.5%815803796785779771760753746728722717708696688677673667663652643
Shares Outstanding0.8%31.0031.0031.0031.0031.0031.0033.0032.0035.0036.0036.0036.00---------
Float----5,600---3,700---5,100---2,500---1,800-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-2.4%152,677156,395114,38582,51880,076136,684108,49196,61946,25670,89472,35362,76157,319105,49859,76344,26749,14856,94064,29246,63034,005
  Share Based Compensation-16.6%4,3105,1655,0074,9065,4385,5935,7945,6534,3723,9814,0473,5702,8712,9612,7622,6165,4452,7079,4665,3853,183
Cashflow From Investing131.6%2,530-7,997-8,662-8,467-9,503-9,220-7,187-11,127-11,208-9,116-6,600-5,997-9,651-7,734-8,643-9,315-5,522-5,730-6,132-3,440-3,842
Cashflow From Financing403.0%7,6601,523-49,272-82,210-52,683-131,121-109,108-123,463-412,0832,431-5,207-50,7799,102-40,2086,777-8,406-40,4458341,795-53,519-23,028
  Buy Backs----59.0023,992120,14647,182-374,717425,950-5,93956,157-47,447-7,58943,238----
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MEDP Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue, net (includes $12.8 million and $15.8 million with related parties for the three months ended March 31, 2024 and 2023, respectively)$ 511,044$ 434,074
Operating expenses:  
Total direct costs355,902303,885
Selling, general and administrative44,08138,027
Depreciation6,6315,408
Amortization361550
Total operating expenses406,975347,870
Income from operations104,06986,204
Other income (expense), net:  
Miscellaneous income, net4,593687
Interest income (expense), net4,120(861)
Total other income (expense), net8,713(174)
Income before income taxes112,78286,030
Income tax provision10,19113,136
Net income$ 102,591$ 72,894
Net income per share attributable to common shareholders:  
Basic (in dollars per share)$ 3.32$ 2.35
Diluted (in dollars per share)$ 3.20$ 2.27
Weighted average common shares outstanding:  
Basic (in shares)30,84331,008
Diluted (in shares)32,00132,155
Direct Costs  
Operating expenses:  
Total direct costs$ 171,492$ 151,068
Reimbursed out-of-pocket expenses  
Operating expenses:  
Total direct costs$ 184,410$ 152,817

MEDP Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 407,010$ 245,449
Accounts receivable and unbilled, net (includes $1.8 million and $2.4 million with related parties at March 31, 2024 and December 31, 2023, respectively)279,166298,400
Prepaid expenses and other current assets (includes $0.3 million with related parties at March 31, 2024 and December 31, 2023)58,72649,979
Total current assets744,902593,828
Property and equipment, net118,600120,589
Operating lease right-of-use assets138,803144,801
Goodwill662,396662,396
Intangible assets, net35,44835,809
Deferred income taxes75,23174,435
Other assets20,40924,970
Total assets1,795,7891,656,828
Current liabilities:  
Accounts payable (includes $2.8 million and $3.1 million with related parties at March 31, 2024 and December 31, 2023, respectively)24,40231,869
Accrued expenses270,926292,961
Advanced billings (includes $10.9 million and $10.1 million with related parties at March 31, 2024 and December 31, 2023, respectively)616,697559,860
Other current liabilities44,62040,441
Total current liabilities956,645925,131
Operating lease liabilities136,156142,122
Deferred income tax liability2,3642,404
Other long-term liabilities29,08228,221
Total liabilities1,124,2471,097,878
Commitments and contingencies (see Note 11)
Shareholders’ equity:  
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at March 31, 2024 and December 31, 202300
Common stock - $0.01 par-value; 250,000,000 shares authorized at March 31, 2024 and December 31, 2023; $30,983,185 and 30,752,292 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively310308
Treasury stock - $70,073 and 70,573 shares at March 31, 2024 and December 31, 2023, respectively(12,235)(12,322)
Additional paid-in capital814,649802,681
Accumulated deficit(119,141)(221,645)
Accumulated other comprehensive loss(12,041)(10,072)
Total shareholders’ equity671,542558,950
Total liabilities and shareholders’ equity$ 1,795,789$ 1,656,828
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
 CEO
 WEBSITEmedpace.com
 INDUSTRYDiagnostics & Research
 EMPLOYEES5600

Medpace Holdings Inc Frequently Asked Questions


What is the ticker symbol for Medpace Holdings Inc? What does MEDP stand for in stocks?

MEDP is the stock ticker symbol of Medpace Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Medpace Holdings Inc (MEDP)?

As of Fri Jul 19 2024, market cap of Medpace Holdings Inc is 13.05 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MEDP stock?

You can check MEDP's fair value in chart for subscribers.

What is the fair value of MEDP stock?

You can check MEDP's fair value in chart for subscribers. The fair value of Medpace Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Medpace Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MEDP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Medpace Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether MEDP is over valued or under valued. Whether Medpace Holdings Inc is cheap or expensive depends on the assumptions which impact Medpace Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MEDP.

What is Medpace Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 19 2024, MEDP's PE ratio (Price to Earnings) is 41.75 and Price to Sales (PS) ratio is 6.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MEDP PE ratio will change depending on the future growth rate expectations of investors.